Confirmation of the amyloidogenic process in posterior cortical atrophy: Value of the Aβ42/Aβ40 ratio

Journal of Alzheimer's Disease

Volumn 33, Issue 3, 2013, Pages 775-780

  Beaufils, Emilie ^a,b   Dufour Rainfray, Diane ^a,b,c   Hommet, Caroline ^a,b,c   Brault, Florence ^a   Cottier, Jean Philippe ^a,b,c   Ribeiro, Maria Joao ^a,b,c   Mondon, Karl ^a,c   Guilloteau, Denis ^a,b,c  

^a UNIVERSITY HOSPITAL OF TOURS   (France)

^b UNIVERSITÉ DE TOURS   (France)

^c Université de Tours   (France)

Author keywords

Alzheimer's disease; amyloid ; biomarker; cerebrospinal fluid; posterior cortical atrophy; tau

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; BIOLOGICAL MARKER; TAU PROTEIN;

ADULT; AGED; AMYLOIDOSIS; ARTICLE; BRAIN CORTEX ATROPHY; CEREBROSPINAL FLUID; CLINICAL ARTICLE; DIAGNOSTIC ERROR; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; IN VIVO STUDY; MALE; MYOCLONUS; PREDICTIVE VALUE; PRIORITY JOURNAL;

EID: 84872439286     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-121267     Document Type: Article

References (28)

1. Benson F, Davis J, Snyder BD (1988) Posterior cortical atrophy. Arch Neurol 45, 789-793.
2. Kas A, de Souza LC, Samri D, Bartolomeo P, Lacomblez L, Kalafat M, Migliaccio R, Thiebaut de Schotten M, Cohen L, Dubois B, Habert MO, SarazinM(2011) Neural correlates of cognitive impairment in posterior cortical atrophy. Brain 134, 1464-1478.
3. Crutch SJ, Lehmann MS, Schott JM, Rabinovici GD, Rossor MN, Fox NC (2012) Posterior cortical atrophy. Lancet Neurol 11, 170-178.
4. Renner JA, Burns JM, Hou CE, McKeel DW Jr, Storandt M, Morris JC (2004) Progressive posterior cortical dysfunction: A clinicopathological series. Neurology 63 1175-1180. (Pubitemid 39350013)
5. Tang-Wai DF, Graff-Radford NR, Boeve BF, Dickson DW, Parisi JE, Crook R, Caselli RJ, Knopman DS, Petersen RC (2004) Clinical, genetic, and neuropathological characteristics of posterior cortical atrophy. Neurology 63, 1168-1174. (Pubitemid 39350012)
6. Baumann TP, Duyar H, Sollberger M, Kuhle J, Regeniter A, Gomez-Mancilla B, Schmidtke K, Monsch AU (2010) CSF-tau and CSF-Abeta(1-42) in posterior cortical atrophy. Dement Geriatr Cogn Disord 29, 530-533.
7. De Souza LC, Lamari F, Belliard S, Jardel C, Houillier C, De Paz R, Dubois B, Sarazin M (2011) Cerebrospinal fluid biomarkers in the differential diagnosis of Alzheimer's disease from other cortical dementias. J Neurol Neurosurg Psychiatry 82, 240-246.
8. De Souza LC, Corlier F, Habert MO, Uspenskaya O, Maroy R, Lamari F, Chupin M, Leh'ericy S, Colliot O, Hahn-Barma V, Samri D, Dubois B, Bottlaender M, Sarazin M (2011) Similar amyloid- burden in posterior cortical atrophy and Alzheimer's disease. Brain 134, 2036-2043.
9. Formaglio M, Costes N, Seguin J, Tholance Y, Le Bars D, Roullet-Solignac I, Mercier B, Krolak-Salmon P, Vighetto A (2011) In vivo demonstration of amyloid burden in posterior cortical atrophy: A case series with PET and CSF findings. J Neurol 258, 1841-1851.
10. Seguin J, Formaglio M, Perret-Liaudet A, Quadrio I, Tholance Y, Rouaud O, Thomas-Anterion C, Croisile B, Mollion H, Moreaud O, Salzmann M, Dorey A, Bataillard M, Coste MH, Vighetto A, Krolak-Salmon P (2011) CSF biomarkers in posterior cortical atrophy. Neurology 76, 1782-1788.
11. Mendez MF, Ghajarania M, Perryman KM (2002) Posterior cortical atrophy: Clinical characteristics and differences compared to Alzheimer's disease. Dement Geriatr Cogn Disord 14, 33-40. (Pubitemid 34621579)
12. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state": A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198.
13. Grober E, Buschke H (1987) Genuine memory deficit in dementia. Dev Neuropsychol 3, 13-36.
14. Van Der Linden M. Coyette F. Poitrenaud J. Kalafat M. Calicis F. Wyns C. Adam S. avec leur ́etalonnage), Van der Linden M, et les membres du GREMEM eds. Solal, Marseille.
15. Van der Linden M, Coyette F, Poitrenaud J, Kalafat M, Calicis F, Wyns C, Adam S, et les membres du GREMEM (2004) L'́epreuve de rappel libre/rappel indic'e 'a 16 items. In L'́evaluation des troubles de la m'emoire: Pr'esentation de quatre tests de m'emoire ́episodique (avec leur ́etalonnage), Van der Linden M, et les membres du GREMEM eds. Solal, Marseille. [15] Rey A (1959) Test de copie et production d'une figure complexe. In Editions du Centre de Psychologie Appliqu'ee, Paris. [16] Rapport LJ, Millis SR, Bonello PJ (1998) Validation of the Warrington theory of visual processing and the Visual Object and Space Perception Battery. J Clin Exp Neuropsychol 20, 211-220.
16. Agniel A, Joanette Y, Doyon B, Duchein C. (1992) Protocole d'́evaluation des gnosies visuelles. In L'Ortho-Edition, Isbergues.
17. Peigneux P, Van der LindenM(2000) Presentation of a cognitive neuropsychological battery for limb apraxia assessment. Rev Neuropsychol 10, 311-362.
18. Mc Khann GM, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology 34, 939-944. (Pubitemid 14076461)
19. Hansson O, ZetterbergH, Buchhave P, Londos E, BlennowK, Minthon L (2006) Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: A follow-up study. Lancet Neurol 5, 228-234. (Pubitemid 43238346)
20. Mattsson N, Zetterberg H, Hansson O, Andreasen N, Parnetti L, Jonsson M, Herukka SK, Van der Flier WM, Blankenstein MA, Ewers M, Rich K, Kaiser E, Verbeek M, Tsolaki M, Mulugeta E, Rosén E, Aarsland D, Visser PJ, Schroder J, Marcusson J, de Leon M, Hampel H, Scheltens P, Pirttila T, Wallin A, Jonhagen ME, Minthon L, Winblad B, Blennow K (2009) CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA302, 385-393.
21. Tapiola T, Alafuzoff I, Herukka SK, Parkkinen L, Hartikainen P, Soininen H, Pirttil?a T (2009) Cerebrospinal fluid betaamyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Arch Neurol 66, 382-389.
22. Welge V, Fiege O, Lewczuk P, Mollenhauer B, Esselmann H, Klafki HW, Wolf S, Trenkwalder C, Otto M, Kornhuber J, Wiltfang J, Bibl M (2009) Combined CSF tau, p-tau181 and amyloid-beta 38/40/42 for diagnosing Alzheimer's disease. J Neural Transm 116, 203-212.
23. Wiltfang J, Esselmann H, Bibl M, H?ull M, Hampel H, Kessler H, Fr?olich L, Schr?oder J, Peters O, Jessen F, Luckhaus C, Perneczky R, Jahn H, Fiszer M, Maler JM, Zimmermann R, Bruckmoser R,Kornhuber J, Lewczuk P (2007) Amyloid beta peptide ratio 42/40 but not A beta 42 correlates with phospho-Tau in patients with low- and high-CSF A beta 40 load. J Neurochem 101, 1053-1059. (Pubitemid 46683864)
24. Lee SE, Rabinovici GD, Mayo MC,Wilson SM, SeeleyWW, DeArmond SJ, Huang EJ, Trojanowski JQ, Growdon ME, Jang JY, Sidhu M, See TM, KarydasAM,Gorno- Tempini ML, Boxer AL, Weiner MW, Geschwind MD, Rankin KP, Miller BL (2011) Clinicopathological correlations in corticobasal degeneration. Ann Neurol 70, 327-340.
25. Mathew R, Bak TH, Hodges JR (2012) Diagnostic criteria for corticobasal syndrome: A comparative study. J Neurol Neurosurg Psychiatry 83, 405-410.
26. Rabinovici GD, Miller BL (2012) Corticobasal syndrome: Overcoming the artificial divide between disorders of cognition and movement. J Neurol Neurosurg Psychiatr 83, 404.
27. Rosenbloom MH, Alkalay A, Agarwal N, Baker SL, O'Neil JP, Janabi M, Yen IV, Growdon M, Jang J, Madison C, Mormino EC, Rosen HJ, Gorno-Tempini ML, Weiner MW, Miller BL, Jagust WJ, Rabinovici GD (2011) Distinct clinical and metabolic deficits in PCA and AD are not related to amyloid distribution. Neurology 76, 1789-1796.
28. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH (2011) The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 263-269.